321: Summit's upcoming cancer results, Recursion's mixed data, and the next big obesity target
The Readout Loud
00:00
Trials and Tribulations in DMD Research
This chapter analyzes a clinical trial's mixed results in the Duchenne muscular dystrophy field, spotlighting a promising RNA-based drug amidst management upheaval. The discussion also covers controversies surrounding data interpretation, investor confidence, and competition in the pharmaceutical landscape.
Transcript
Play full episode
